Celularity Inc. / Fundamentals
Income statement
- Net revenue
€38.42M - Cost of goods sold
€17.25M - Gross profit
€26.42M - SG&A expenses
€47.91M - R&D expenses
€12.77M - EBITDA
-€50.22M - D&A
€6.41M - EBIT
-€40.63M - Interest expenses
€6.84M - EBT
-€63.47M - Tax expenses
€0.00 - Net income
-€63.47M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€30.81M - Changes in working capital
€16.41M - Operating cash flow
-€2.19M - Capex
€78.40K - Other investing cash flow
-€1.34M - Net investing cash flow
-€1.37M - Total cash dividends paid
€0.00 - Issuance of common stock
€2.99M - Debt repayment
€12.41M - Other financing cash flow
€13.45M - Net financing cash flow
€3.89M - Foreign exchange effects
€0.00 - Net change in cash
€329.11K - Cash at end of period
€9.42M - Free cash flow
-€2.11M
Balance sheet
- Cash and cash equivalents
€743.52K - Cash and short-term investments
€743.52K - Total receivables
€9.61M - Inventory
€3.80M - Other current assets
€721.98K - Total current assets
€14.87M - Property, plant & equipment
€59.83M - Goodwill
€6.33M - Intangible assets
€7.33M - Long-term investments
€0.00 - Other non-current assets
€15.27M - Total non-current assets
€88.76M - Total assets
€103.63M - Accounts payable
€21.02M - Short-term debt
€5.98M - Other current liabilities
€29.62M - Total current liabilities
€59.64M - Long-term debt
€54.46M - Deferred tax liabilities
€7.75K - Other non-current liabilities
€9.02M - Total non-current liabilities
€65.95M - Total liabilities
€125.60M - Common stock
€1.72K - Retained earnings
-€813.32M - Other equity
-€2.58K - Total equity
-€21.97M - Total liabilities and shareholders' equity
€103.63M
Company information
- Market capitalization
€904.94K - Employees
120 - Enterprise Value
€71.40M
Company ratios
- Gross margin
-
68.8% Much better than peer group: -743.8% - EBITDA margin
-
-130.7% Much better than peer group: -7,598.1% - EBIT margin
-
-105.8% Much better than peer group: -7,345.7% - EBT margin
-
-165.2% Much better than peer group: -6,653.7% - Net margin
-
-165.2% Much better than peer group: -6,960.2% - ROE
-
288.9% Much better than peer group: -109.7% - ROA
-
-61.2% Much better than peer group: -546.5% - Asset turnover
-
37.1% Better than peer group: 17.9% - FCF margin
-
-5.9% Much better than peer group: -6,439.2% - FCF yield
-250.7% - Efficiency ratio
230.7% - Net sales per employee
-
€320.14K - Net income per employee
-
-€528.91K